Assertio Holdings, Inc.
NASDAQ:ASRT
0.8 (USD) • At close January 14, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Assertio Holdings, Inc. |
Symbool | ASRT |
Munteenheid | USD |
Prijs | 0.797 |
Beurswaarde | 76,067,163 |
Dividendpercentage | 0% |
52-weken bereik | 0.73 - 1.8 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Daniel A. Peisert |
Website | https://www.assertiotx.com |
An error occurred while fetching data.
Over Assertio Holdings, Inc.
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis;
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)